L.ThakkerD
That's based on research involving rats, however, and no studies done on humans have established the same connection
The Danish pharma giant announced in October that the oral form of semaglutide, the active ingredient in Ozempic and Wegovy, was shown to reduce the risk of major adverse heart events by 14% among people with Type 2 diabetes and cardiovascular disease and/or chronic kidney disease, compared with patients who were given a placebo
But its certainly promising. New research builds on evidence suggesting that semaglutide, the active ingredient in GLP-1 drugs like Ozempic and Wegovy, could help treat alcohol use disorder
Zinc can activate the Nrf2/HO-1 pathway, increase the contents of GPX4, SOD and GSH, reduce the levels of lipid peroxides, MDA and ROS, and effectively reverse the behavioral and structural changes after SCI